News stories about Edap Tms (NASDAQ:EDAP) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Edap Tms earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 46.18936643813 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:
- Urology Lasers Market Enhancement in Medical Sector 2018 to 2025 (sbwire.com)
- Global High-intensity Focused Ultrasound (HIFU) Therapy Market (2018-2025) to Grow at a CAGR of 21.8 … (thedailytimes.com)
- Are you looking for sizzling stock?: EDAP TMS SA (EDAP), Kewaunee Scientific Corporation (KEQU) (newsregistrar.com)
- Analysts Anticipate Edap Tms SA (EDAP) to Announce ($0.02) Earnings Per Share (americanbankingnews.com)
Edap Tms remained flat at $$3.14 during mid-day trading on Friday, Marketbeat Ratings reports. The company had a trading volume of 19,752 shares, compared to its average volume of 63,877. The stock has a market capitalization of $91.05 million, a PE ratio of -314.00 and a beta of 0.62. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.04 and a current ratio of 2.45. Edap Tms has a 12 month low of $2.07 and a 12 month high of $4.25.
A number of analysts recently commented on the company. ValuEngine upgraded Edap Tms from a “hold” rating to a “buy” rating in a research report on Monday, July 16th. HC Wainwright reiterated a “buy” rating and set a $6.50 price objective on shares of Edap Tms in a research report on Monday, July 2nd. Finally, TheStreet upgraded Edap Tms from a “d+” rating to a “c” rating in a research report on Tuesday, June 26th.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
See Also: Trading Penny Stocks
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.